Andrew Left, author, editor, and founder of Citron Research, announced he would end his business’ practice of publishing short-seller reports.
After decades in business, Citron became an institution on Wall Street. In 2015, it uncovered “phantom sales” at Valeant Pharmaceuticals and concluded, “the whole thing is a fraud.” Citron’s reporting brought on an SEC investigation and the stock price cratered 90%.
The GameStop Corp. (NYSE: GME) was Citron’s latest target. In early January, as the stock price rose above $40 per share, Citron initiated a short position and called for the price to fall back below $20.
Citron’s Left claims to have covered all but a small portion of the firm’s short position in the $90s for a “100% loss.”
This morning, Left posted a new video announcing that after 20 years of exposing fraud and “protecting the individual,” he would end the practice of writing short-seller reports.
In the video, he states that his firm was started “to be against the establishment” but has since “actually become the establishment.”
Posts contain affiliate links. Timothysykes.com may get compensated for affiliate posts and purchases through links.